Axsome Therapeutics AXSM Total Revenue
Total Revenue at other companies
Segments
By product
See fullOther financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's total revenue?
- Axsome Therapeutics (AXSM) reported total revenue of $191.2M in Q1 2026.
- How has Axsome Therapeutics's total revenue changed year-over-year?
- Axsome Therapeutics's total revenue increased by 57.4% year-over-year, from $121.46M to $191.2M.
- What is the long-term trend for Axsome Therapeutics's total revenue?
- Over 3 years (2022 to 2025), Axsome Therapeutics's total revenue has grown at a 133.7% compound annual growth rate (CAGR), from $50.04M to $638.5M.
- What does total revenue mean?
- The total amount of money generated from business operations before any expenses are deducted.
- How do you interpret total revenue?
- An increase indicates successful market adoption and product sales growth, while a decrease suggests market share loss or pricing pressure.
- How does total revenue compare across companies?
- Standard across all biopharmaceutical companies; benchmarked against peers based on product portfolio maturity.